These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16172090)

  • 1. Topiramate in opiate withdrawal- comparison with clonidine and with carbamazepine/mianserin.
    Zullino DF; Krenz S; Zimmerman G; Miozzari A; Rajeswaran R; Kolly S; Khazaal Y
    Subst Abus; 2004 Dec; 25(4):27-33. PubMed ID: 16172090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topiramate in opiate withdrawal.
    Zullino DF; Cottier AC; Besson J
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1221-3. PubMed ID: 12452551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association carbamazepine-mianserin in opiate withdrawal: a double blind pilot study versus clonidine.
    Bertschy G; Bryois C; Bondolfi G; Velardi A; Budry P; Dascal D; Martinet C; Baettig D; Baumann P
    Pharmacol Res; 1997 May; 35(5):451-6. PubMed ID: 9308074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficiency of a carbamazepine-mianserin combination scheme in opiate detoxification.
    Zullino DF; Krenz S; Favrat B; Zimmermann G; Bertschy G; Besson J
    Hum Psychopharmacol; 2004 Aug; 19(6):425-30. PubMed ID: 15303247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of polydrug-using opiate dependents during withdrawal: towards a standardisation of treatment.
    Kristensen Ø; Lølandsmo T; Isaksen A; Vederhus JK; Clausen T
    BMC Psychiatry; 2006 Nov; 6():54. PubMed ID: 17107609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program--a randomized, double blind, placebo controlled, prospective study.
    Herman I; Shamir D; Bar-Hamburger R; Pick CG; Schreiber S
    Addict Behav; 2005 Jul; 30(6):1154-67. PubMed ID: 15925125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate related obsessive-compulsive disorder.
    Ozkara C; Ozmen M; Erdogan A; Yalug I
    Eur Psychiatry; 2005 Jan; 20(1):78-9. PubMed ID: 15642451
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal.
    Carnwath T; Hardman J
    Drug Alcohol Depend; 1998 May; 50(3):251-4. PubMed ID: 9649979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital.
    Kahn A; Mumford JP; Rogers GA; Beckford H
    Drug Alcohol Depend; 1997 Jan; 44(1):57-61. PubMed ID: 9031821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
    Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
    J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate use in alprazolam addiction.
    Michopoulos I; Douzenis A; Christodoulou C; Lykouras L
    World J Biol Psychiatry; 2006; 7(4):265-7. PubMed ID: 17071548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol withdrawal and carbamazepine.
    Butler D; Messiha FS
    Alcohol; 1986; 3(2):113-29. PubMed ID: 2872902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
    Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate in benzodiazepine withdrawal.
    Cheseaux M; Monnat M; Zullino DF
    Hum Psychopharmacol; 2003 Jul; 18(5):375-7. PubMed ID: 12858324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal.
    Yu E; Miotto K; Akerele E; Montgomery A; Elkashef A; Walsh R; Montoya I; Fischman MW; Collins J; McSherry F; Boardman K; Davies DK; O'Brien CP; Ling W; Kleber H; Herman BH
    Drug Alcohol Depend; 2008 Sep; 97(1-2):158-68. PubMed ID: 18508207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertensive urgency induced by an interaction of mirtazapine and clonidine.
    Abo-Zena RA; Bobek MB; Dweik RA
    Pharmacotherapy; 2000 Apr; 20(4):476-8. PubMed ID: 10772378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans.
    Walsh SL; Strain EC; Bigelow GE
    Addiction; 2003 Apr; 98(4):427-39. PubMed ID: 12653813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.
    Umbricht A; Hoover DR; Tucker MJ; Leslie JM; Chaisson RE; Preston KL
    Drug Alcohol Depend; 2003 Apr; 69(3):263-72. PubMed ID: 12633912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures.
    Aldenkamp AP; Baker G; Mulder OG; Chadwick D; Cooper P; Doelman J; Duncan R; Gassmann-Mayer C; de Haan GJ; Hughson C; Hulsman J; Overweg J; Pledger G; Rentmeester TW; Riaz H; Wroe S
    Epilepsia; 2000 Sep; 41(9):1167-78. PubMed ID: 10999556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How clonidine works in easing opiate withdrawal.
    Trommer PR
    Postgrad Med; 1982 May; 71(5):44. PubMed ID: 6122204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.